Transformational advances: The future of bioscience research
Billionaire philanthropist Paul Allen committed $100 million to fund life science advanced research. Through the newly created Paul G. Allen Frontiers Group, Allen hopes to support and explore the landscape of bioscience, as the group’s news release confirmed.
The Microsoft co-founder and Seattle Seahawks owner announced on March 23rd his million dollar pledge to fund studies in the said field, in the hopes of further exploring new possibilities in bioscience.
Part of the Frontiers Group launch was the announcement of its pioneering projects with four new Allen Distinguished Investigators (ADI) and two Allen Discovery Centers in partnership with two renowned universities. Forbes reported that $20 million grant was awarded to eight years of research projects at Stanford University, led by bioengineering professor Markus Covert, and at Tufts University, led by biology professor Michael Levin.
Allen, who was a two-time cancer survivor, launched several science frontiers such as brain and cell science through his nonprofit research group, the Allen Institute. University of California professor Jennifer Doudna was also a grant recipient whose new gene editing technology research helped pioneer Clustered Regularly-Interspaced Short Palindromic Repeats (CRISPR), a study which also proved to be beneficial in cancer research.
Dedicated to answering questions on bioscience and accelerating research worldwide, the Allen Institute also published a research called the Cell Types Database which is a tool that helped scientists to identify cell types used in specific brain processes. Other research that the group published includes constructing brain taxonomy which helped identify brain parts and their specific functions.
Several studies made within the last decade proved Allen’s belief that further science research could uncover numerous discoveries beneficial to humans.
Seven years ago, experts predicted the convergence of various bioscience research including genomics, proteomics and stem cell research. Several ambitious programs were laid out as future of bioscience including breakthroughs in medicine, life sciences, and technologies. These emerging technologies and breakthroughs are believed to have impact human health care today until 2020.
One study discussed the increasing use of nonablative radiofrequency in skin rejuvenation and body contouring instead of laser light technology. Although the process of laser light delivered through the skin leads to cellular regeneration, the use of Radiofrequency energy delivers less tissue damage because RF uses electric energy instead of light source. Interestingly, such advancements in technologies are also used in communication, such as RF-based equipment network extender from 5BARz International. This same RF basis can now be used in non-invasive surgeries.
Another recent scientific research discovered that superbugs were capable of various medical uses such as curing diseases and creating an artificial life form. The new bacterial cell called Synthia 3.0 contains fewer genes and its creation allows several scientific breakthroughs such as customizing genes that blend with clean biofuels and absorb carbon dioxide. Ethical issues surround the discovery, but scientists are optimistic about its potential in life science.
In the news release, Allen passionately explained that it was only through investments in science and out-of-the-box approaches that people could find the kind of transformational advances they seek. Allen also assured that there are rewards that come with this endeavor, despite a series of failures and setbacks.
Indeed, emerging technologies and human’s constant thirst for discovering life paves the way for several studies and research that help treat diseases and prolong life.